Evidence for OTUD-6B participation in B lymphocytes cell cycle after cytokine stimulation

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Xu, Zhongping ^a,d   Zheng, Yufang ^b   Zhu, Yufei ^a,d   Kong, Xiangyin ^a,c,d   Hu, Landian ^a,c,d  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D2; CYSTEINE; CYTOKINE; MESSENGER RNA; OVARIAN TUMOR DOMAIN CONTAINING 6B PROTEIN; REGULATOR PROTEIN; TRISTETRAPROLIN; UNCLASSIFIED DRUG; OVARIAN TUMOR DOMAIN CONTAINING 6B PROTEIN, HUMAN; OVARIAN TUMOR DOMAIN-CONTAINING 6B PROTEIN, HUMAN; PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL STRAIN; CELL STRAIN F3; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE MUTATION; GENETIC CONSERVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN STABILITY; WILD TYPE; ANIMAL; B LYMPHOCYTE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CYTOLOGY; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL CYCLE; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; ENDOPEPTIDASES; HUMANS; MICE; RNA, MESSENGER;

EID: 79251537162     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014514     Document Type: Article

References (45)

1. DeSalle LM, Pagano M (2001) Regulation of the G1 to S transition by the ubiquitin pathway. FEBS Lett 490: 179-189.
2. Muratani M, Tansey WP (2003) How the ubiquitin-proteasome system controls transcription. Nat Rev Mol Cell Biol 4: 192-201.
3. Loureiro J, Ploegh HL (2006) Antigen presentation and the ubiquitinproteasome system in host-pathogen interactions. Adv Immunol 92: 225-305.
4. Song L, Rape M (2008) Reverse the curse-the role of deubiquitination in cell cycle control. Curr Opin Cell Biol 20: 156-163.
5. Zhu Y, Carroll M, Papa FR, Hochstrasser M, D'Andrea AD (1996) DUB-1, a deubiquitinating enzyme with growth-suppressing activity. Proc Natl Acad Sci U S A 93: 3275-3279.
6. Burrows JF, McGrattan MJ, Rascle A, Humbert M, Baek KH, et al. (2004) DUB-3, a cytokine-inducible deubiquitinating enzyme that blocks proliferation. J Biol Chem 279: 13993-14000.
7. Amerik AY, Hochstrasser M (2004) Mechanism and function of deubiquitinating enzymes. Biochim Biophys Acta 1695: 189-207.
8. Hanna J, Hathaway NA, Tone Y, Crosas B, Elsasser S, et al. (2006) Deubiquitinating enzyme Ubp6 functions noncatalytically to delay proteasomal degradation. Cell 127: 99-111.
9. Komander D, Clague MJ, Urbe S (2009) Breaking the chains: structure and function of the deubiquitinases. Nat Rev Mol Cell Biol 10: 550-563.
10. Caligaris-Cappio F, Ferrarini M (1996) B cells and their fate in health and disease. Immunol Today 17: 206-208.
11. Milne CD, Paige CJ (2006) IL-7: a key regulator of B lymphopoiesis. Semin Immunol 18: 20-30.
12. Acosta-Rodriguez EV, Merino MC, Montes CL, Motran CC, Gruppi A (2007) Cytokines and chemokines shaping the B-cell compartment. Cytokine Growth Factor Rev 18: 73-83.
13. Baek KH, Kim MS, Kim YS, Shin JM, Choi HK (2004) DUB-1A, a novel deubiquitinating enzyme subfamily member, is polyubiquitinated and cytokineinducible in B-lymphocytes. J Biol Chem 279: 2368-2376.
14. Zhu Y, Lambert K, Corless C, Copeland NG, Gilbert DJ, et al. (1997) DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes. J Biol Chem 272: 51-57.
15. Burrows JF, McGrattan MJ, Johnston JA (2005) The DUB/USP17 deubiquitinating enzymes, a multigene family within a tandemly repeated sequence. Genomics 85: 524-529.
16. Catic A, Fiebiger E, Korbel GA, Blom D, Galardy PJ, et al. (2007) Screen for ISG15-crossreactive deubiquitinases. PLoS One 2: e679.
17. Blanchard C, Mingler MK, Vicario M, Abonia JP, Wu YY, et al. (2007) IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J Allergy Clin Immunol 120: 1292-1300.
18. Patke A, Mecklenbrauker I, Erdjument-Bromage H, Tempst P, Tarakhovsky A (2006) BAFF controls B cell metabolic fitness through a PKC beta- and Aktdependent mechanism. J Exp Med 203: 2551-2562.
19. Buzzeo MP, Yang J, Casella G, Reddy V (2007) Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis. Exp Hematol 35: 1456-1465.
20. Kimura K, Wakamatsu A, Suzuki Y, Ota T, Nishikawa T, et al. (2006) Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 16: 55-65.
21. Kayagaki N, Phung Q, Chan S, Chaudhari R, Quan C, et al. (2007) DUBA: a deubiquitinase that regulates type I interferon production. Science 318: 1628-1632.
22. Almeida S, Maillard C, Itin P, Hohl D, Huber M (2008) Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol 128: 587-593.
23. Xue L, Igaki T, Kuranaga E, Kanda H, Miura M, et al. (2007) Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila. Dev Cell 13: 446-454.
24. Ihle JN (1995) Cytokine receptor signalling. Nature 377: 591-594.
25. Lim LP, Glasner ME, Yekta S, Burge CB, Bartel DP (2003) Vertebrate microRNA genes. Science 299: 1540.
26. Stoecklin G, Colombi M, Raineri I, Leuenberger S, Mallaun M, et al. (2002) Functional cloning of BRF1, a regulator of ARE-dependent mRNA turnover. Embo J 21: 4709-4718.
27. Carballo E, Lai WS, Blackshear PJ (1998) Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005.
28. DeMaria CT, Brewer G (1996) AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation. J Biol Chem 271: 12179-12184.
29. Emmons J, Townley-Tilson WH, Deleault KM, Skinner SJ, Gross RH, et al. (2008) Identification of TTP mRNA targets in human dendritic cells reveals TTP as a critical regulator of dendritic cell maturation. Rna 14: 888-902.
30. Zhu Y, Pless M, Inhorn R, Mathey-Prevot B, D'Andrea AD (1996) The murine DUB-1 gene is specifically induced by the betac subunit of interleukin-3 receptor. Mol Cell Biol 16: 4808-4817.
31. Klug G (1993) The role of mRNA degradation in the regulated expression of bacterial photosynthesis genes. Mol Microbiol 9: 1-7.
32. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, et al. (2001) AU binding proteins recruit the exosome to degrade ARE-containing mRNAs. Cell 107: 451-464.
33. Levy NS, Chung S, Furneaux H, Levy AP (1998) Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR. J Biol Chem 273: 6417-6423.
34. Shaw G, Kamen R (1986) A conserved AU sequence from the 39 untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46: 659-667.
35. Hau HH, Walsh RJ, Ogilvie RL, Williams DA, Reilly CS, et al. (2007) Tristetraprolin recruits functional mRNA decay complexes to ARE sequences. J Cell Biochem 100: 1477-1492.
36. Nakayama KI, Hatakeyama S, Nakayama K (2001) Regulation of the cell cycle at the G1-S transition by proteolysis of cyclin E and p27Kip1. Biochem Biophys Res Commun 282: 853-860.
37. Sherr CJ (1996) Cancer cell cycles. Science 274: 1672-1677.
38. Whitfield ML, George LK, Grant GD, Perou CM (2006) Common markers of proliferation. Nat Rev Cancer 6: 99-106.
39. Bouchard C, Dittrich O, Kiermaier A, Dohmann K, Menkel A, et al. (2001) Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Mycdependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev 15: 2042-2047.
40. Vicari L, Eramo A, Manzella L, Malaguarnera L, Iannolo G, et al. (2006) The PU.1 transcription factor induces cyclin D2 expression in U937 cells. Leukemia 20: 2208-2210.
41. Dey A, She H, Kim L, Boruch A, Guris DL, et al. (2000) Colony-stimulating factor-1 receptor utilizes multiple signaling pathways to induce cyclin D2 expression. Mol Biol Cell 11: 3835-3848.
42. Huang W, Chang HY, Fei T, Wu H, Chen YG (2007) GSK3 beta mediates suppression of cyclin D2 expression by tumor suppressor PTEN. Oncogene 26: 2471-2482.
43. Sowa ME, Bennett EJ, Gygi SP, Harper JW (2009) Defining the human deubiquitinating enzyme interaction landscape. Cell 138: 389-403.
44. Liu YY, Cabot MC (2004) Development of a mammalian Tet-on expression cell line: glucosylceramide synthase regulates TNF-alpha-induced apoptosis. Methods Mol Biol 249: 177-192.
45. Peritz T, Zeng F, Kannanayakal TJ, Kilk K, Eiriksdottir E, et al. (2006) Immunoprecipitation of mRNA-protein complexes. Nat Protoc 1: 577-580.